Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IGKC anticorps (AA 1-107)

IGKC Reactivité: Humain IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7156094
  • Antigène Tous les produits IGKC
    IGKC (Immunoglobulin kappa Constant (IGKC))
    Épitope
    • 3
    • 2
    • 2
    • 1
    • 1
    AA 1-107
    Reactivité
    • 29
    • 2
    Humain
    Hôte
    • 17
    • 14
    Lapin
    Clonalité
    • 24
    • 7
    Polyclonal
    Conjugué
    • 24
    • 3
    • 2
    • 1
    • 1
    Cet anticorp IGKC est non-conjugé
    Application
    • 12
    • 12
    • 11
    • 10
    • 7
    • 6
    • 6
    • 4
    • 4
    • 4
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Immunoglobulin kappa constant protein (1-107AA)
    Isotype
    IgG
  • Indications d'application
    Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    IGKC (Immunoglobulin kappa Constant (IGKC))
    Autre désignation
    IGKC (IGKC Produits)
    Synonymes
    anticorps HCAK1, anticorps IGKCD, anticorps Km, anticorps IGKC, anticorps Igk-C, anticorps immunoglobulin kappa constant, anticorps immunoglobulin kappa constant L homeolog, anticorps IGKC, anticorps LOC708048, anticorps igkc, anticorps igkc.L, anticorps Igkc
    Sujet

    Background: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).

    Aliases: IGKCImmunoglobulin kappa constant antibody, Ig kappa chain C region antibody, Ig kappa chain C region AG antibody, Ig kappa chain C region CUM antibody, Ig kappa chain C region EU antibody, Ig kappa chain C region OU antibody, Ig kappa chain C region ROY antibody, Ig kappa chain C region TI antibody

    UniProt
    P01834
Vous êtes ici: